Longer durability a goal for new methods of posterior segment drug delivery

WAILEA, Hawaii — Novel drug delivery methods could provide longer durability for posterior segment therapies, according to a speaker at Retina 2024.
According to Baruch D. Kuppermann, MD, PhD, intravitreal injection has been the mainstay of posterior segment drug delivery, but it has flaws in its ability to deliver a sustained effect.
“It’s a lot of drug that we put in the eye,” Kuppermann said. “It rapidly leaves the eye, so frequent re-treatment is necessary.”
Intravitreal injections are effective, but shorter periods of durability are becoming less

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart